Le Lézard
Classified in: Health, Business
Subjects: SVY, POL

New Brief: Cash-Based Support Would Empower Vulnerable to Buy Private Health Insurance, Create More Effective Safety Net

SACRAMENTO, Calif., June 21, 2023 /PRNewswire/ -- Providing cash-based support to the vulnerable to purchase private health insurance would increase access to quality healthcare at roughly the same per enrollee costs as Medicaid programs -- finds the latest paper in the Coverage Denied series released today by the Center for Medical Economics and Innovation at the nonpartisan Pacific Research Institute.

Click to download the brief

"Tens of millions are stuck in a flawed government-run healthcare system that provides sub-par care to patients, imposes huge taxpayer costs, and harms the broader healthcare system," said Dr. Wayne Winegarden, director of PRI's Center for Medical Economics and the series author. "By providing cash-based support, we can empower the vulnerable to buy private insurance, expand access to care, improve efficiency and promote innovation benefitting all patients."

"Establishing an Efficient Healthcare Safety Net" documents that Medicaid, which is supposed to provide access to quality healthcare regardless of income, is failing to serve its purpose. Compared to private insurance, Medicaid provides patients with low quality care, underpays providers, and imposes massive taxpayer costs.

The study presents data showing that Medicaid costs are more expensive per enrollee compared to private health insurance for individuals ($8,984 per enrollee for Medicaid versus $7,911 for private) and roughly the same for family/household coverage ($22,463 per household for Medicaid versus $22,461 for private).

Winegarden argues that unless Medicaid provides superior healthcare compared to private coverage, it is more efficient to replace the program with a cash-based system enabling people to purchase private health insurance.

The Coverage Denied series documents how the third-party payment system has turned insurance companies or government -- as the largest healthcare payers -- into gatekeepers restricting access to care, while imposing greater financial burdens on patients.

Reforming Medicaid is an essential component of reforms to remove the disincentives driving up health care costs and reduce healthcare quality and create a more efficient system. Other reforms suggested in the series include:

"Patients and doctors should be empowered to make healthcare decisions, not third-party payers, drug middlemen or government," said Winegarden. "A patient-centered healthcare payment system would better control rising costs, increase health outcomes, and improve efficiency."

The Pacific Research Institute (www.pacificresearch.org) champions freedom, opportunity, and personal responsibility through free-market policy ideas. Follow PRI on Facebook, Twitter, and LinkedIn.

Media Contact:
Emeline McClellan
(202) 970-9742
[email protected]

SOURCE Pacific Research Institute

These press releases may also interest you

at 21:30
The "Hydroxypropyl Methylcellulose Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F" report has been added to  ResearchAndMarkets.com's offering. The latest industry analysis on the Hydroxypropyl Methylcellulose...

at 21:00
The "Asia-Pacific Contrast Media Agent and Injector System Market - Analysis and Forecast, 2022-2026" report has been added to  ResearchAndMarkets.com's offering. The Asia-Pacific contrast media agent and injector system market was valued at $1.98...

at 20:50
Viking Therapeutics, Inc. ("Viking") , a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced the pricing of its  underwritten public offering of 6,471,000...

at 20:34
The Honourable Mark Holland, Minister of Health, will make an announcement related to An Act Respecting Pharmacare. There will be a virtual media technical briefing with Government of Canada officials prior to the press conference. DateFebruary 29,...

at 19:30
The "Protein Expression Market - A Global and Regional Analysis: Focus on Application, End User, Product, Expression System, and Region - Analysis and Forecast, 2023-2033" report has been added to  ResearchAndMarkets.com's offering. The global...

at 19:20
Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) ("Genomma Lab" or "the Company"), one of the leading pharmaceutical and personal care product companies in Mexico with an expanding international presence, today announced that MSCI, one of the...

News published on and distributed by: